Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)
Titel:
Safety, tolerability and pharmacokinetics of crizotinib in combination with cytotoxic chemotherapy for pediatric patients with refractory solid tumors or anaplastic large cell lymphoma (ALCL): a Children’s Oncology Group phase 1 consortium study (ADVL1212)
Auteur:
Greengard, Emily Mosse, Yael P. Liu, Xiaowei Minard, Charles G. Reid, Joel M. Voss, Stephan Wilner, Keith Fox, Elizabeth Balis, Frank Blaney, Susan M. Adamson, Peter C. Weigel, Brenda J.